Cargando…
The Omnipresence of DYRK1A in Human Diseases
The increasing population will challenge healthcare, particularly because the worldwide population has never been older. Therapeutic solutions to age-related disease will be increasingly critical. Kinases are key regulators of human health and represent promising therapeutic targets for novel drug c...
Autores principales: | Deboever, Estelle, Fistrovich, Alessandra, Hulme, Christopher, Dunckley, Travis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408930/ https://www.ncbi.nlm.nih.gov/pubmed/36012629 http://dx.doi.org/10.3390/ijms23169355 |
Ejemplares similares
-
DYRK1A antagonists rescue degeneration and behavioural deficits of in vivo models based on amyloid-β, Tau and DYRK1A neurotoxicity
por: Zhu, Bangfu, et al.
Publicado: (2022) -
Dyrk1 inhibition improves Alzheimer's disease‐like pathology
por: Branca, Caterina, et al.
Publicado: (2017) -
These omnipresent ions
por: Flerov, G N, et al.
Publicado: (1998) -
Omnipresence of inflammasome activities in inflammatory bone diseases
por: Alippe, Yael, et al.
Publicado: (2019) -
Human anelloviruses: diverse, omnipresent and commensal members of the virome
por: Kaczorowska, Joanna, et al.
Publicado: (2020)